Utah Medical Products, Inc. (UTMD)

Utah Medical Products Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	10.85	11.29	13.87	16.64	16.47	14.79
Depreciation & Amortization	2.98	3.01	2.85	6.37	7.08	7.28
Stock-Based Compensation	0.41	0.37	0.26	0.23	0.18	0.17
Other Adjustments	-0.21	-0.29	-0.34	-0.71	-0.37	-0.03
Change in Receivables	0.2	0.33	-0.78	2.27	-0.53	-1.13
Changes in Inventories	0.09	1.2	0.59	-0.67	-2.35	-0.49
Changes in Accounts Payable	0.28	0.21	-0.07	-0.46	0.46	-0.02
Changes in Accrued Expenses	-1.1	-1.37	-1.5	-1.42	0.25	0.71
Changes in Other Operating Activities	-0.12	-0.05	-0.03	0.05	-0.06	-0.08
Operating Cash Flow	13.34	14.69	14.83	22.28	21.15	21.2
Operating Cash Flow Growth	-4.87%	-0.94%	-33.44%	5.36%	-0.26%	5.29%
Capital Expenditures	-0.32	-0.37	-0.23	-0.64	-0.81	-0.55
Sale of Property, Plant & Equipment	-	-	0.03	-	-	-
Purchases of Intangible Assets	-	-	-0.01	-	-0.01	-
Investing Cash Flow	-0.32	-0.37	-0.21	-0.64	-0.82	-0.55
Issuance of Common Stock	-	-	0.39	0.12	0.17	0.56
Repurchase of Common Stock	-5.26	-8.36	-19.97	-	-2.5	-
Net Common Stock Issued (Repurchased)	-5.26	-8.36	-19.58	0.12	-2.32	0.56
Common Dividends Paid	-3.96	-3.98	-4.26	-4.28	-3.16	-11.47
Financing Cash Flow	-9.22	-12.34	-23.84	-4.17	-5.48	-10.91
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.28	0.8	-0.68	0.34	-0.77	-0.36
Net Cash Flow	4.08	2.78	-9.89	17.82	14.08	9.38
Free Cash Flow	13.02	14.32	14.6	21.64	20.34	20.65
Free Cash Flow Growth	-9.09%	-1.92%	-32.53%	6.41%	-1.52%	7.13%
FCF Margin	34.69%	37.18%	35.70%	43.09%	38.90%	42.10%
Free Cash Flow Per Share	4.06	4.42	4.17	5.95	5.58	5.64
Levered Free Cash Flow	7.48	13.91	15.47	19.86	21.05	21.64
Unlevered Free Cash Flow	10.54	11.74	12.82	17.12	20.35	21.5

Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q